IME — Imagin Medical Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.16m
- CA$11.12m
Annual cashflow statement for Imagin Medical, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.15 | 0.053 | 0.034 | 7.65 | -0.945 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.833 | 0.343 | 0.199 | -0.296 | 0.763 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.63 | -4.04 | -4.11 | -4.09 | -2.63 |
| Capital Expenditures | -0.013 | -0.033 | -0.033 | -0.007 | -0.781 |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.013 | -0.033 | -0.033 | -0.007 | -0.781 |
| Financing Cash Flow Items | -0.244 | 0 | — | — | 0.333 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.2 | 0.524 | 1.9 | 4.34 | 3.18 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.57 | -3.55 | -2.25 | 0.238 | -0.225 |